Precision radiation boost aims to outsmart deadly brain cancer
NCT ID NCT05653622
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a higher radiation dose to the most aggressive parts of a glioblastoma tumor, as seen on a special FDOPA PET scan, can help people live longer. It includes 75 adults who are too frail for standard treatment or had only a partial surgery or biopsy. The goal is to improve survival without increasing side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME, ADULT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHRU de Nancy
RECRUITINGNancy, De, 5400, France
Contact Email: •••••@•••••
Contact
-
Centre Paul Strauss
RECRUITINGStrasbourg, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
ICL
RECRUITINGVandœuvre-lès-Nancy, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Adaptive radiation aims to outsmart aggressive brain tumors
- Electric fields plus targeted radiation may boost survival in recurrent glioblastoma
- Brain cancer breakthrough? new trial delivers drug straight to tumor
- Surgical flap may open door to better brain tumor treatment
- New drug combo shows promise in tough brain cancer
- New radiation boost shows promise for elderly glioblastoma patients